Instruction for use: Methacin

Active substance: Metocinium iodide

ATX Code

A03A Drugs for treatment of functional gastrointestinal disorders

Pharmacological group

M. Cholinolytics

The nosological classification (ICD-10)

K11.7 Disturbances of secretion of salivary glands

hyperptyalism, xerostomia

K25 Gastric ulcer

Helicobacter pylori, Pain syndrome in gastric ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, Inflammation of the gastric mucosa, Inflammation of the gastrointestinal mucosa, Benign gastric ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Aggravation gastroduodenita on the background of peptic ulcer, Exacerbation of peptic ulcer, The aggravation of gastric ulcer, The organic gastrointestinal disease, Peptic ulcer of the stomach and duodenum, Postoperative gastric ulcer, Recurrent ulcers, Symptomatic gastric ulcers, Chronic inflammatory disease of the upper gastrointestinal tract, associated with Helicobacter pylori, Helicobacter pylori eradication, Erosive and ulcerative lesions of the stomach, Erosive lesions of the stomach, The erosion of the gastric mucosa, Peptic ulcer disease, Stomach ulcer, Gastric lesion, Ulcerative lesions of the stomach, Symptomatic ulcers of the stomach and duodenum

K26 Duodenal Ulcer

Pain with duodenal ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Exacerbation of peptic ulcer, The worsening of duodenal ulcer, Peptic ulcer of the stomach and duodenum, Relapse of duodenal ulcers, Symptomatic ulcers of the stomach and duodenum, Helicobacter pylori eradication, Erosive and ulcerative lesions of the duodenum, Erosive-ulcerative lesions of duodenal ulcers associated with Helicobacter pylori, Erosive lesions of the duodenum, Duodenal ulcer, Ulcerative lesions of the duodenum]

K29.5 Chronic gastritis, unspecified

gastroenteritis, Metaplasia gastric mucosa, The pain in chronic gastritis with high acidity, chronic Gastritis, Gastroenteritis, Acute gastroenteritis, Chronic gastritis, Chronic diseases of the digestive system, Chronic autoimmune gastritis, Chronic gastritis, Chronic gastritis in acute stage, Chronic gastritis with normal secretory function, Chronic gastritis with normal secretory function of the stomach, Chronic gastritis with normal secretion, Chronic gastritis with increased and normal gastric secretory function, Chronic gastritis with secretory function, Chronic gastritis with increased secretion, Chronic gastritis with secretory function of the stomach, Chronic gastritis with a reduced secretory function, Chronic gastritis with secretory insufficiency

N23 Renal colic unspecified

Pain in renal colic, Pain smooth muscle spasm, Pain spasm of smooth muscles (renal and biliary colic, intestinal spasms, dysmenorrhea), Pain spasm of smooth muscles of internal organs, Pain spasm of smooth muscles of internal organs (kidney and biliary colic, intestinal spasms, dysmenorrhea), renal Colic, ureteral colic, Renal colic, Renal colic with urolithiasis, Kidney disease, Spasm of smooth muscle in diseases of the urinary system, The spasm of the urinary tract, The spasm of the ureter, The spasm of the ureters, Spasms of the urinary tract, Spasms of the urinary tract

R10.4 Other and unspecified abdominal pain

Abdominal pain, Gastrointestinal spasm, intestinal colic, Colic in infants, The feeling of fullness, Resi abdominal, Spasm of smooth muscle in diseases of the digestive tract, The spasm of the biliary tract, Biliary tract spasm, enterospasm, Spasm of the digestive tract, Spasms of the digestive tract smooth muscle, stomach Cramps, gastrointestinal spasms, Spastic condition of the gastrointestinal tract, intestinal tenesmus, Feeling of fullness, Baby colic

Structure and Composition

1 ampoule with 1 ml injection solution contains 1 mg metotsiniya iodide; in a cardboard box 10 pcs.

1 tablet - 2 mg; in blisters of 10 pieces.

pharmachologic effect

Mode of action - antispasmodic.

Working with m-cholinergic receptors, shields them from neurotransmitter (acetylcholine).

Indications

Spasm of smooth muscles of internal organs (stomach ulcer and duodenal ulcer, chronic gastritis, renal and hepatic colic); salivary hypersecretion and bronchial glands.

Contraindications

Glaucoma, prostatic hypertrophy.

Side effects

Dry mouth, constipation, difficulty urinating.

Dosing and Administration

in / m, a / c, n / k - at 0.5-2 ml of 0.1% solution daily dose - 6 mg. Inside - 4.2 mg 2-3 times a day, the highest single dose of - 5 mg daily - 15 mg.

Storage conditions

In the dark spot.

Keep out of the reach of children.

shelf life

2 mg tablets - 5 years.

injection of 1 mg / ml - 3 years.

Do not use beyond the expiration date printed on the package.